Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report.

diffuse idiopathic pulmonary neuroendocrine cell hyperplasia epidermal growth factor receptor lung adenocarcinoma tyrosine kinase inhibitor

Journal

Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441

Informations de publication

Date de publication:
11 2022
Historique:
revised: 01 09 2022
received: 10 06 2022
accepted: 04 09 2022
pubmed: 23 9 2022
medline: 4 11 2022
entrez: 22 9 2022
Statut: ppublish

Résumé

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH), a rare condition, is characterized by pathological proliferation of neuroendocrine cells. Some of them are localized to the airway mucosa, and others locally infiltrate to form tumorlets and nodules. Here, we present a patient with lung adenocarcinoma accompanied by DIPNECH, making the latter difficult to distinguish from multiple pulmonary metastases. The patient, a 72-year-old Japanese woman, was diagnosed as having stage IVA lung adenocarcinoma because she had multiple nodules in both lungs. Mutation of epidermal growth factor receptor gene having been found in the primary tumor, treatment with osimertinib was started. This resulted in shrinkage of the primary tumor, but not the multiple pulmonary nodules. To determine whether these lung nodules were indeed lung metastases, we performed right upper lobectomy with lymphadenectomy and wedge resection of the right lower lobe. On pathological examination, the primary tumor was diagnosed as invasive adenocarcinoma, whereas the multiple pulmonary nodules were diagnosed as DIPNECH manifesting as tumorlets. Therefore, the final diagnosis was stage IA1 lung adenocarcinoma accompanied by DINPECH. The patient had no recurrences 1 year after the operation without any additional treatment. This is a rare case of lung adenocarcinoma accompanied by DIPNECH presenting as multiple pulmonary nodules. DIPNECH should be included in the differential diagnosis of multiple pulmonary nodules.

Identifiants

pubmed: 36134429
doi: 10.1111/1759-7714.14662
pmc: PMC9626319
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

3076-3079

Informations de copyright

© 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Références

Am J Respir Crit Care Med. 2011 Jul 1;184(1):8-16
pubmed: 21471097
Lung Cancer. 2017 Aug;110:77-79
pubmed: 28648688
Br J Radiol. 2011 Jan;84(997):e14-7
pubmed: 21172958
Thorac Cancer. 2022 Nov;13(21):3076-3079
pubmed: 36134429
AJR Am J Roentgenol. 2020 Dec;215(6):1312-1320
pubmed: 33021835
J Med Case Rep. 2008 Jan 25;2:21
pubmed: 18218143
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008

Auteurs

Sho Inomata (S)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Yuki Matsumura (Y)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Yasuyuki Kobayashi (Y)

Department of Diagnostic Pathology, Fukushima Medical University, Fukushima, Japan.

Hikaru Yamaguchi (H)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Masayuki Watanabe (M)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Yuki Ozaki (Y)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Satoshi Muto (S)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Naoyuki Okabe (N)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Yutaka Shio (Y)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Hiroyuki Suzuki (H)

Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH